 | Up a level |
Hartmann, Phillipp, Duan, Yi, Miyamoto, Yukiko, Demir, Munevver 
ORCID: 0000-0002-7050-797X, Lang, Sonja, Hasa, Elda, Stern, Patrick, Yamashita, Dennis, Conrad, Mary, Eckmann, Lars and Schnabl, Bernd
(2022).
Colesevelam ameliorates non-alcoholic steatohepatitis and obesity in mice.
Hepatol. Int., 16 (2).
S. 359 - 371.
NEW YORK:
SPRINGER.
ISSN 1936-0541
Kasper, Philipp ORCID: 0000-0002-6218-2239, Selle, Jaco ORCID: 0000-0002-4981-0931, Vohlen, Christina, Wilke, Rebecca, Kuiper-Makris, Celien ORCID: 0000-0002-7940-9612, Klymenko, Oleksiy, Bae-Gartz, Inga ORCID: 0000-0002-4061-503X, Schoemig, Charlotte, Quaas, Alexander, Schumacher, Bjorn, Demir, Munevver ORCID: 0000-0002-7050-797X, Buerger, Martin, Lang, Sonja, Martin, Anna, Steffen, Hans-Michael ORCID: 0000-0001-6562-3549, Goeser, Tobias, Doetsch, Jorg and Alcazar, Miguel A. Alejandre
(2022).
Perinatal Obesity Induces Hepatic Growth Restriction with Increased DNA Damage Response, Senescence, and Dysregulated Igf-1-Akt-Foxo1 Signaling in Male Offspring of Obese Mice.
Int. J. Mol. Sci., 23 (10).
BASEL:
MDPI.
ISSN 1422-0067
Demir, Munevver ORCID: 0000-0002-7050-797X, Lang, Sonja, Hartmann, Phillipp ORCID: 0000-0003-3658-3335, Duan, Yi, Martin, Anna, Miyamoto, Yukiko, Bondareva, Marina ORCID: 0000-0001-7893-0580, Zhang, Xinlian, Wang, Yanhan, Kasper, Philipp ORCID: 0000-0002-6218-2239, Bang, Corinna, Roderburg, Christoph, Tacke, Frank, Steffen, Hans-Michael, Goeser, Tobias, Kruglov, Andrey ORCID: 0000-0002-4597-2087, Eckmann, Lars, Starkel, Peter, Fouts, Derrick E. and Schnabl, Bernd
(2022).
The fecal mycobiome in non-alcoholic fatty liver disease.
J. Hepatol., 76 (4).
S. 788 - 801.
AMSTERDAM:
ELSEVIER.
ISSN 1600-0641
Loosen, Sven H., Schulze-Hagen, Max, Vucur, Mihael, Gorgulho, Joao, Paffenholz, Pia, Benz, Fabian, Mohr, Raphael, Demir, Munevver ORCID: 0000-0002-7050-797X, Wree, Alexander ORCID: 0000-0002-2968-1335, Kuhl, Christiane, Trautwein, Christian, Tacke, Frank, Bruners, Philipp ORCID: 0000-0002-5790-3687, Luedde, Tom and Roderburg, Christoph
(2021).
Elevated soluble urokinase plasminogen activator receptor serum levels indicate poor survival following transarterial chemoembolization therapy for hepatic malignancies: An exploratory analysis.
JGH Open, 5 (3).
S. 356 - 364.
HOBOKEN:
WILEY.
ISSN 2397-9070